Feedback Control Through cGMP-Dependent Protein Kinase Contributes to Differential Regulation and Compartmentation of cGMP in Rat Cardiac Myocytes
暂无分享,去创建一个
[1] D. Kass,et al. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. , 2009, Pharmacology & therapeutics.
[2] D. Cooper,et al. Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. , 2007, Physiological reviews.
[3] D. Kass,et al. Compartmentalization of Cardiac &bgr;-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5 , 2007 .
[4] J. Burnett,et al. Natriuretic peptides and therapeutic applications , 2007, Heart Failure Reviews.
[5] Franz Hofmann,et al. cGMP-dependent Protein Kinase Type I Inhibits TAB1-p38 Mitogen-activated Protein Kinase Apoptosis Signaling in Cardiac Myocytes* , 2006, Journal of Biological Chemistry.
[6] M. Silberbach,et al. Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments , 2006, The Journal of general physiology.
[7] D. Cooper,et al. Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes , 2006, Circulation.
[8] M. Zaccolo,et al. Compartmentalized Phosphodiesterase-2 Activity Blunts &bgr;-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway , 2006, Circulation research.
[9] D. Dickey,et al. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. , 2006, Endocrine reviews.
[10] F. Hofmann,et al. A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK‐I alpha does not regulate NPR‐A , 2006, Biochemistry.
[11] D. Kass,et al. Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in Humans , 2005 .
[12] A. Papapetropoulos,et al. Soluble guanylyl cyclase: more secrets revealed. , 2005, Cellular signalling.
[13] H. Weiss,et al. Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes , 2005, Experimental biology and medicine.
[14] D. Kass,et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.
[15] D. Cooper,et al. Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes , 2004, Journal of Biological Chemistry.
[16] M. Zaccolo,et al. cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.
[17] Suhn Hee Kim,et al. High and Low Gain Switches for Regulation of cAMP Efflux Concentration: Distinct Roles for Particulate GC- and Soluble GC-cGMP-PDE3 Signaling in Rabbit Atria , 2004, Circulation research.
[18] H. Drexler,et al. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. , 2003, Cardiovascular research.
[19] C. Roberts,et al. Atrial Natriuretic Peptide Induces Natriuretic Peptide Receptor-cGMP-dependent Protein Kinase Interaction* , 2003, Journal of Biological Chemistry.
[20] A. Friebe,et al. Regulation of Nitric Oxide‐Sensitive Guanylyl Cyclase , 2003, Circulation research.
[21] J. Kotera,et al. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5. , 2003, The Biochemical journal.
[22] P. Cohen,et al. The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.
[23] F. Hofmann,et al. Direct activation of PDE5 by cGMP , 2003, The Journal of cell biology.
[24] J. Beavo,et al. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain , 2003, The EMBO journal.
[25] J. Kotera,et al. Phosphorylation of Isolated Human Phosphodiesterase-5 Regulatory Domain Induces an Apparent Conformational Change and Increases cGMP Binding Affinity* , 2002, The Journal of Biological Chemistry.
[26] M. Conti,et al. Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)* , 2002, The Journal of Biological Chemistry.
[27] F. Hofmann,et al. Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.
[28] U. Kaupp,et al. Cyclic nucleotide-gated ion channels. , 2002, Physiological reviews.
[29] K. Murthy. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. , 2001, The Biochemical journal.
[30] D. Kass,et al. Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] Roger Y. Tsien,et al. Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Fischmeister,et al. G protein‐mediated inhibitory effect of a nitric oxide donor on the L‐type Ca2+ current in rat ventricular myocytes , 2001, The Journal of physiology.
[33] M. S. Taylor,et al. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Rodríguez-Pascual,et al. Nitric Oxide‐Sensitive Guanylyl Cyclase Activity Inhibition Through Cyclic GMP‐Dependent Dephosphorylation , 2000, Journal of neurochemistry.
[35] U. Walter,et al. KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells* , 2000, The Journal of Biological Chemistry.
[36] J. Corbin,et al. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. , 2000, European journal of biochemistry.
[37] M. Kinoshita,et al. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.
[38] F. Lezoualc’h,et al. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca2+ current in rat ventricular myocytes , 1999, British journal of pharmacology.
[39] K. Fujishige,et al. Novel Alternative Splice Variants of cGMP-binding cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.
[40] T. Hunter,et al. Phosphorylation of the Kinase Homology Domain Is Essential for Activation of the A-Type Natriuretic Peptide Receptor , 1998, Molecular and Cellular Biology.
[41] L. Potter. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. , 1998, Biochemistry.
[42] C. Barnstable,et al. Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel , 1998, Journal of Molecular Neuroscience.
[43] J. Corbin,et al. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[44] E. Degerman,et al. Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)* , 1997, The Journal of Biological Chemistry.
[45] T. Lincoln,et al. Phosphorylation of the Inositol 1,4,5-Trisphosphate Receptor , 1996, The Journal of Biological Chemistry.
[46] M. Conti,et al. Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase , 1995, The Journal of Biological Chemistry.
[47] Michael Chinkers. Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] R Fischmeister,et al. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.
[49] D. Garbers,et al. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. , 1992, The Journal of biological chemistry.
[50] C. Lugnier,et al. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles. , 1992, European journal of pharmacology.
[51] R Fischmeister,et al. Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[52] F. Hofmann,et al. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. , 1988, The Biochemical journal.
[53] R. Fischmeister,et al. Atrial Natriuretic Factor Regulates the Calcium Current in Frog Isolated Cardiac Cells , 1988, Circulation research.
[54] T. Lincoln,et al. Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-1). , 1978, The Journal of biological chemistry.
[55] D. Blumenthal,et al. Phosphorylation of cardiac troponin by guanosine 3':5'-monophosphate-dependent protein kinase. , 1978, The Journal of biological chemistry.
[56] M. M. Appleman,et al. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. , 1971, Biochemistry.
[57] R. Lefkowitz,et al. Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases , 2012 .
[58] F. Hofmann,et al. Function of cGMP-dependent protein kinases as revealed by gene deletion. , 2006, Physiological reviews.
[59] Stepan Gambaryan,et al. Fluorescent sensors for rapid monitoring of intracellular cGMP , 2005, Nature Methods.
[60] D. Cooper,et al. Negative Feedback Exerted by PKA and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes , 2004 .
[61] Keith A. Jones,et al. Differential effects of soluble and particulate guanylyl cyclase on Ca(2+) sensitivity in airway smooth muscle. , 2002, Journal of applied physiology.
[62] P. Smits,et al. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. , 1993, Circulation.